Table 1.
Laboratory data on admission
| Hematology | ABGA (O2 5 L/m) | ||||
| WBC | 14,400 /μl | CRP | 6.4 mg/dl | pH | 6.91 |
| neu. | 74% | Amylase | 139 IU/L | pCO2 | 33.7 mmHg |
| lym. | 22% | Elastase1 | 1939 ng/dl | PO2 | 184 mmHg |
| mon. | 3% | Lipase | 119 U/L | HCO3− | 6.5 mmol/L |
| eosino. | 1% | Na | 129 mEq/l | BE | −26.1 mmol/L |
| RBC | 468 × 104 /μl | K | 6.7 mEq/l | ||
| Hb | 13.5 g/dl | Cl | 95 mEq/l | Urine analysis | |
| Ht | 40.7% | Glu | 427 mg/dl | pH | 5.0 |
| Plt | 47.8 × 104 /μl | HbA1c | 6.2% | Protein | (2+) |
| Serum C-peptide | 0.04 ng/ml | Glucose | (4+) | ||
| Chemistry | TSH | 2.14 μIU/ml | Blood | (1+) | |
| AST | 14 IU/L | F-T4 | 1.03 ng/ml | Ketone | (4+) |
| ALT | 12 IU/L | Urine C-peptide | 0.5 μg/day | ||
| γ-GTP | 12 IU/L | ||||
| T-Bil | 0.5 mg/dl | Coagulation | Autoantibodies | ||
| ALP | 328 IU/l | PT | 12.3 sec | GAD Ab | < 5.0 U/ml |
| TP | 9 mg/dl | APTT | 30.9 sec | IA-2 Ab | (−) |
| Alb | 4.2 g/dl | FDP | 8.47 μg/ml | Insulin Ab | < 0.4 U/ml |
| CK | 29 IU/l | D-dimer | 5.48 μg/ml | ||
| CRE | 0.87 mg/dl | HLA haplotype | |||
| BUN | 22 mg/dl | DR8, DR12, DQ7, DQ4 | |||
Ab antibody, ABGA arterial blood gas analysis, Alb albumin, ALP alkaline phosphatase, ALT alanine aminotransferase, APTT activated partial thromboplastin time, AST aspartate aminotransferase, BE base excess, BUN blood urea nitrogen, CK creatine kinase, CRE creatinine, CRP C-reactive protein, eosino. eosinophils, FDP fibrin degradation product, F-T4 free thyroxine, GAD glutamic acid decarboxylase, γ-GTP gamma-glutamyl transpeptidase, GLU glucose, Hb hemoglobin, HbA1c glycated hemoglobin, HCO3− bicarbonate, HLA human leukocyte antigens, Ht hematocrit, lym. lymphocytes, mon. monocytes, neu. neutrophils, pCO2 partial pressure of carbon dioxide, pO2 partial pressure of oxygen, Plt platelets, PT prothrombin time, RBC red blood cells, T-Bil total bilirubin, TP total protein, TSH thyroid-stimulating hormone, WBC white blood cells